These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36621199)

  • 1. Mandatory prescription drug monitoring programs and overlapping prescriptions of opioids and benzodiazepines: Evidence from Kentucky.
    Nguyen T; Meille G; Buchmueller T
    Drug Alcohol Depend; 2023 Feb; 243():109759. PubMed ID: 36621199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing.
    Strickler GK; Zhang K; Halpin JF; Bohnert ASB; Baldwin GT; Kreiner PW
    Drug Alcohol Depend; 2019 Jun; 199():1-9. PubMed ID: 30954863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mandatory Review of Prescription Drug Monitoring Program Before Issuance of a Controlled Substance Results in Overall Reduction of Prescriptions Including Opioids and Benzodiazepines.
    Manders L; Abd-Elsayed A
    Pain Physician; 2020 Jun; 23(3):299-304. PubMed ID: 32517396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Provider Compliance With Kentucky's Prescription Drug Monitoring Program's Mandate To Query Patient Opioid History.
    Carey CM; Meille G; Buchmueller TC
    Health Aff (Millwood); 2021 Mar; 40(3):461-468. PubMed ID: 33646863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Postoperative Opioid Prescriptions Before and After Implementation of a Mandatory Prescription Drug Monitoring Program.
    Shenoy R; Wagner Z; Kirkegaard A; Romanelli RJ; Mudiganti S; Mariano L; Martinez M; Zanocco K; Watkins KE
    JAMA Health Forum; 2021 Oct; 2(10):e212924. PubMed ID: 35977161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mandatory use of prescription drug monitoring program and benzodiazepine prescribing among U.S. Medicaid enrollees.
    Liang D; Guo H; Shi Y
    Subst Abus; 2021; 42(3):294-301. PubMed ID: 31697195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between State Policies on Improving Opioid Prescribing in 2 States and Opioid Overdose Rates Among Reproductive-aged Women.
    Ji X; Haight SC; Ko JY; Cox S; Barfield WD; Zhang K; Guy GP; Li R
    Med Care; 2021 Feb; 59(2):185-192. PubMed ID: 33273289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring the Effectiveness of Benzodiazepine Prescriptions Control in Community Setting Using Prescription Drug Monitoring Program (PDMP).
    Agrawal R; Verma S; Halappanavar M
    Community Ment Health J; 2021 Jul; 57(5):920-925. PubMed ID: 32666418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in opioid and other analgesic prescribing following voluntary and mandatory prescription drug monitoring program implementation: A time series analysis of early outcomes.
    Nielsen S; Picco L; Russell G; Pearce C; Andrew NE; Lubman DI; Bell JS; Buchbinder R; Xia T
    Int J Drug Policy; 2023 Jul; 117():104053. PubMed ID: 37209441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between prescription drug monitoring programs use mandates and prescription stimulants received by Medicaid enrollees.
    Gunadi C; Shi Y
    Drug Alcohol Rev; 2023 Nov; 42(7):1658-1666. PubMed ID: 37946605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in opioid prescribing after implementation of mandatory registration and proactive reports within California's prescription drug monitoring program.
    Castillo-Carniglia A; González-Santa Cruz A; Cerdá M; Delcher C; Shev AB; Wintemute GJ; Henry SG
    Drug Alcohol Depend; 2021 Jan; 218():108405. PubMed ID: 33234299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription drug monitoring programs use mandates and prescription stimulant and depressant quantities.
    Gunadi C; Shi Y
    BMC Public Health; 2023 Jul; 23(1):1326. PubMed ID: 37434122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Prescription Drug Monitoring Program Use With Opioid Prescribing and Health Outcomes: A Comparison of Program Users and Nonusers.
    Deyo RA; Hallvik SE; Hildebran C; Marino M; Springer R; Irvine JM; O'Kane N; Van Otterloo J; Wright DA; Leichtling G; Millet LM; Carson J; Wakeland W; McCarty D
    J Pain; 2018 Feb; 19(2):166-177. PubMed ID: 29054493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating Emergency Department Opioid Prescribing Behaviors After Education About Mandated Use of the Pennsylvania Prescription Drug Monitoring Program.
    Martello J; Cassidy B; Mitchell A
    J Addict Nurs; 2018; 29(3):196-202. PubMed ID: 30180006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription History Before Opioid Overdose Death: PDMP Data and Responsible Prescribing.
    Shreffler J; Shaw I; Berrones A; Huecker M
    J Public Health Manag Pract; 2021 Jul-Aug 01; 27(4):385-392. PubMed ID: 32810066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the Use of a Mandatory Prescription Drug Monitoring Program With Prescribing Practices for Patients Undergoing Elective Surgery.
    Stucke RS; Kelly JL; Mathis KA; Hill MV; Barth RJ
    JAMA Surg; 2018 Dec; 153(12):1105-1110. PubMed ID: 30140927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of prescription drug monitoring program mandate on postoperative opioid prescriptions in children.
    Theodorou CM; Jackson JE; Rajasekar G; Nuño M; Yamashiro KJ; Farmer DL; Hirose S; Brown EG
    Pediatr Surg Int; 2021 May; 37(5):659-665. PubMed ID: 33433663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Examination of Concurrent Opioid and Benzodiazepine Prescribing in 9 States, 2015.
    Guy GP; Zhang K; Halpin J; Sargent W
    Am J Prev Med; 2019 Nov; 57(5):629-636. PubMed ID: 31564606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Provider Prescription Drug Monitoring Program Utilization and Self-Auditing-A Pilot Study.
    Brown WC; Whitted K
    J Dr Nurs Pract; 2020 Jul; 13(2):142-147. PubMed ID: 32817503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.